Evotec (EVO) Institutional Ownership $5.44 +0.34 (+6.67%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Evotec (NASDAQ:EVO)CurrentInstitutional OwnershipPercentage5.81%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$129.38MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$348.40K Get EVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Evotec stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVO Institutional Buying and Selling by Quarter Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Evotec Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Wellington Management Group LLP2,634,434$9.62M0.0%+29.7%0.743% 10/24/2024 Clear Harbor Asset Management LLC28,600$104K0.0%N/A0.008% 10/23/2024 Mediolanum International Funds Ltd140,383$512K0.0%N/A0.040% 8/20/2024 Novo Holdings A S14,829,842$71.18M3.6%N/A4.185% 8/13/2024 DCF Advisers LLC114,953$552K0.3%+140.5%0.032% 8/12/2024 Vanguard Personalized Indexing Management LLC19,233$87K0.0%N/A0.005% 5/24/2024Cetera Advisors LLC24,043$188K0.0%N/A0.007% 3/5/2024 Mubadala Investment Co PJSC4,597,701$53.93M0.2%N/A1.297% 2/13/2024 Optiver Holding B.V.80,810$945K0.0%+643.1%0.023% 2/8/2024 Quadrant Capital Group LLC2,130$25K0.0%N/A0.001% 1/31/2024 Federated Hermes Inc.576,933$6.74M0.0%-0.3%0.163% 1/30/2024 Zurcher Kantonalbank Zurich Cantonalbank174,266$2.04M0.0%-13.9%0.049% 11/13/2023 Optiver Holding B.V.10,874$107K0.0%-68.0%0.003% 11/13/2023 Federated Hermes Inc.578,533$5.71M0.0%-22.9%0.163% 10/25/2023 Zurcher Kantonalbank Zurich Cantonalbank202,368$2.00M0.0%-6.2%0.057% (Data available from 1/1/2016 forward) EVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVO shares? During the previous two years, 12 institutional investors and hedge funds held shares of Evotec. The most heavily invested institutionals were Novo Holdings A S ($71.18M), Mubadala Investment Co PJSC ($53.93M), Wellington Management Group LLP ($9.62M), Federated Hermes Inc. ($6.74M), Zurcher Kantonalbank Zurich Cantonalbank ($2.04M), Optiver Holding B.V. ($945K), and DCF Advisers LLC ($552K).Learn more on EVO's institutional investors. What percentage of Evotec stock is owned by institutional investors? 5.81% of Evotec stock is owned by institutional investors. Learn more on EVO's institutional investor holdings. Which institutional investors have been buying Evotec stock? Of the 10 institutional investors that purchased Evotec stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Novo Holdings A S ($14.83M), Mubadala Investment Co PJSC ($4.60M), Wellington Management Group LLP ($602.86K), Mediolanum International Funds Ltd ($140.38K), Optiver Holding B.V. ($69.94K), DCF Advisers LLC ($67.16K), and Clear Harbor Asset Management LLC ($28.60K). How much institutional buying is happening at Evotec? Institutional investors have bought a total of 20,381,882 shares in the last 24 months. This purchase volume represents approximately $129.38M in transactions. Which Evotec major shareholders have been selling company stock? The following institutional investors have sold Evotec stock in the last 24 months: Federated Hermes Inc. ($173.07K), Zurcher Kantonalbank Zurich Cantonalbank ($41.40K), and Optiver Holding B.V. ($23.08K). How much institutional selling is happening at Evotec? Institutional investors have sold a total of 237,551 shares in the last 24 months. This volume of shares sold represents approximately $2.40M in transactions. Related Companies Ascendis Pharma A/S Major Shareholders Legend Biotech Major Shareholders Elanco Animal Health Major Shareholders Cytokinetics Major Shareholders Blueprint Medicines Major Shareholders Nuvalent Major Shareholders Viking Therapeutics Major Shareholders Lantheus Major Shareholders Arcellx Major Shareholders Crinetics Pharmaceuticals Major Shareholders This page (NASDAQ:EVO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
